Examkin

Soru

Zorluk: OrtaPathology and Biopsy Interpretation

A 62-year-old retired agricultural worker visits his primary care physician after his spouse noticed an enlarging, irregularly bordered skin lesion on his upper back over the past eight months. Examination reveals a 1.2-cm asymmetric plaque with variegated colors of black, brown, and blue. An excisional biopsy with 2-mm margins is performed. The preliminary pathologic diagnosis confirms invasive cutaneous melanoma. The physician is reviewing the synoptic pathology report to determine the appropriate clinical staging and definitive surgical management plan. Which of the following histopathologic features reported in the biopsy are the primary determinants of the tumor (T) category for staging this patient's melanoma according to current guidelines? (Select all that apply)

  1. Breslow tumor thickness in millimetersCevap
  2. Presence or absence of microscopic epidermal ulcerationCevap
  3. C
    Clark level of anatomic invasion
  4. D
    Dermal mitotic rate per square millimeter
  5. E
    Density of tumor-infiltrating lymphocytes

Cevap

The primary determinants are the Breslow tumor thickness in millimeters and the presence or absence of microscopic epidermal ulceration.
According to the current AJCC staging guidelines for cutaneous melanoma, the T-category is determined primarily by the Breslow thickness (measured in millimeters from the granular layer of the epidermis to the deepest invasive tumor cell) and the presence or absence of microscopic epidermal ulceration. These two distinct histopathologic features directly guide the width of definitive surgical margins and the indications for sentinel lymph node biopsy.

Adım Adım Çözüm

1
Identify the patient's diagnosis and the clinical task.
The patient has invasive cutaneous melanoma, and the task is to interpret the pathology report to establish the T-category for staging.
Accurate staging dictates the definitive surgical margin size and the need for a sentinel lymph node biopsy.
2
Recall the current American Joint Committee on Cancer (AJCC) staging criteria for melanoma.
The 8th edition AJCC guidelines use Breslow thickness and ulceration status as the key variables for the T-category.
Staying updated on how pathologic variables translate into clinical staging is essential for Step 3 patient management.
3
Differentiate primary staging determinants from prognostic features.
While mitotic rate and TILs provide prognostic value, they do not change the T-category.
Ensures precise application of staging rules without being distracted by ancillary pathologic data.

Anahtar Kavram

In the current staging guidelines for cutaneous melanoma, the T-category (tumor stage) is determined almost exclusively by the Breslow thickness and the presence or absence of tumor ulceration.
Tahmini Süre:1m 15s
Bu soruyu puanla

Konular

Pathology and Biopsy Interpretation

Bu konudan daha fazla soru